# Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

> **NCT00304135** · PHASE2,PHASE3 · COMPLETED · sponsor: **Federation Francophone de Cancerologie Digestive** · enrollment: 34 (actual)

## Conditions studied

- Extrahepatic Bile Duct Cancer
- Gallbladder Cancer
- Liver Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00304135
- **Lead sponsor:** Federation Francophone de Cancerologie Digestive
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2016-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304135, "Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00304135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*